SCHEMBL30017995

SCHEMBL30017995

COc1cc2nc(-c3ccc(Oc4cccc(Cl)c4)cc3)nc(N)c2cc1OCCCN1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 4/20 0.52
▸ RAF1 P04049 2/20 0.52
▸ MAPK3 P27361 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ KDR P35968 4/20 0.49
▸ EGFR P00533 4/20 0.49
▸ SRC P12931 7/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ FGFR1 P11362 1/20 0.47
▸ FLT1 P17948 1/20 0.47
▸ FLT4 P35916 1/20 0.47
▸ AXL P30530 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ TLR9 Q9NR96 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ BCR P11274 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ PDPK1 O15530 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28965139 1.00 MAP2K1 (0.52) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL28959164 0.93 MAPT (0.52) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL28959214 0.91 MAP2K1 (0.52) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL30017992 0.91 MAP2K1 (0.52) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL28959203 0.90 ALDH1A1 (0.57) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL30017764 0.90 ALDH1A1 (0.57) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL30017307 0.90 EGFR (0.56) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL28959167 0.90 MAP2K1 (0.51) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL28959198 0.90 EGFR (0.56) MAP2K1RAF1MAPK3MAPK1KDR
SCHEMBL30017460 0.90 MAP2K1 (0.51) MAP2K1RAF1MAPK3MAPK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403557-A Quinoline and quinazoline compounds as fourth-generation EGFR (epidermal growth factor receptor) inhibitor and application thereof 华东理工大学 2022-11-29 — — CN disclosed
Send feedback